(Q35892167)

11 August 2017

1 reference

title

Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs (English)

1 reference

11 August 2017

Bramah N Singh

1

1 reference

11 August 2017

Nitin Wadhani

series ordinal

2

1 reference

11 August 2017

publication date

1 September 2004

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

11 August 2017

published in

1 reference

11 August 2017

volume

9 Suppl 1

1 reference

11 August 2017

page(s)

S85-97

1 reference

New ideas about atrial fibrillation 50 years on.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Drug-induced prolongation of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Antiarrhythmic drugs: a reorientation in light of recent developments in the control of disorders of rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Effect of Altering Potassium Concentration on the Action of Lidocaine and Diphenylhydantoin on Rabbit Atrial and Ventricular Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Amiodarone: Historical development and pharmacologic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Controlling Cardiac Arrhythmias by Lengthening Repolarization: Rationale from Experimental Findings and Clinical Considerationsa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Cellular electropharmacology of amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Barium-induced nondriven action potentials as a model of triggered potentials from early afterdepolarizations: significance of slow channel activity and differing effects of quinidine and amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

Partial fatty acid oxidation inhibitors for stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900107

10.1177/107424840400900107

21 January 2018

Identifiers

DOI

0 references

1 reference